维普期刊资源整合服务平台（V6.5）

220篇 您的检索式：作者名="Bonner JA"

选中清除导出查看参考文献查看引证文献引用追踪共11页首页上一页第1页下一页末页 /11 跳转

	题名	作者	年代	出处	被引量
1	Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck显示文摘	Harari PM Giralt J et a1	2006	New Engl J Med2006，354，6：	1
2	Long-term results of a phase Ⅲ trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung caneer显示文摘	Schild SE Bonner JA Shanahan TG	2004	Int J Ra- diat Oncol Biol Phys2004，59，4：	1
3	Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer显示文摘	Schild SE Bonner JA Shanahan TG	2004	Int J Radiat Oncol Biol Plays2004，43，2：	1
4	Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers显示文摘	Bonner JA Raish KP Trummell HQ	2000	J Clin Oncol2000，18，21：	1
5	Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer:5-year survival data from a phase 3 randomised trial,and relation between cetuximab-induced rash and survival显示文摘	Bonner JA Harari PM Giralt J	2010	Lancet Oncol2010，11，1：	1
6	Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck显示文摘	Bonner JA Harari PM Giralt J	2006	N Engl J Med2006，354，6：	1
7	Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck显示文摘	Bonner JA Harari PM Giralt J	2006	N Engl J Med2006，354，6：	1
8	Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer:5-year survival data from a phase 3 randomised trial,and relation between cetuximab-induced rash and survival显示文摘	Bonner JA Harari PM Giralt J	2010	Lancet Oncol2010，11，1：	1
9	Significance of neuron-spcific enolase levels before and during therapy for small cell lung cancer显示文摘	Bonner JA Sloan JA Rowland KMJ	2008	Clin Cancer Rea2008，6，：	1
10	Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer显示文摘	Bonner JA Sloon JA Rowland KMJ	2000	Clin Cancer Res2000，6，：	1
11	显示文摘	Bonner JA Sloan JA Rowland KM	2000	Clin Cancer Res2000，6，2：	1
12	Cetuximab Aug-ments Cytotoxicity with Poly (ADP-Ribose) Polymerase inhibi-tion in Head and Neck显示文摘	Nowsheen S Bonner JA Lobuglio AF	2011	Cancer2011，6，8：	1
13	Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck显示文摘	Bonner JA Harari PM Girah J	2006	N Engl J Med2006，354，6：	1
14	Radiotherapy plus cetuximad for locoregionally advanced head and neck cancer: 5-year survival data from a phase Ⅲ randomised trial, and relation between cetuximab-induced rash and survival显示文摘	Bonner JA Harari PM Giralt J	2010	Lancet Oncol2010，11，1：	1
15	Biochemical characterisation of para-aminophenol-induced nephrotoxic lesions in the F344 rat显示文摘	Gartland KP Bonner FW Timbrell JA Nicholson JK	1989	Arch Toxicol1989，63，2：	1
16	Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck 显示文摘	BONNER JA HARARI PM GIRALT J	2006	N Engl J Med2006，354，6：	1
17	Adjuvant radiotherapy for squamous cell carcinoma of the tongue base: improved local-regional disease control compared with surgery alone 显示文摘	Nisi KW Foote RL Bonner JA	1998	Int J Radiat Oncol Biol Phys1998，41，2：	1
18	Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5- year survival data from a phase 3 randomised trial, and relation between eetuximab-induced rash and survival 显示文摘	BONNER JA HARARI PM GIRALT J	2010	Lancet Oncol2010，11，1：	1
19	Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck 显示文摘	Bonner JA Harari PM Abdollahi A	2006	Engl J Med2006，354，：	1
20	Predictors of sub clinical nodal involvement in clinical stages Ⅰ and Ⅱ non-small cell lung cancer: Implications in the inoperable and three-dimensional dose-escalation settings 显示文摘	Bonner JA Gould PM	1999	Int J Radiat Oncol Biol Phys1999，43，：	1

返回顶部每页显示：

共11页首页上一页第1页下一页末页 /11 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示